CATALOGO DEI PRODOTTI DELLA RICERCA

Fassio, Angelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.913
EU - Europa 5.584
AS - Asia 4.486
SA - Sud America 636
AF - Africa 181
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.821
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.757
RU - Federazione Russa 2.588
SG - Singapore 1.815
CN - Cina 1.164
IT - Italia 699
GB - Regno Unito 646
BR - Brasile 503
DE - Germania 457
VN - Vietnam 404
HK - Hong Kong 385
SE - Svezia 265
FR - Francia 257
IE - Irlanda 256
IN - India 152
KR - Corea 141
FI - Finlandia 130
BD - Bangladesh 98
CA - Canada 88
JP - Giappone 83
AR - Argentina 56
NL - Olanda 56
MX - Messico 44
ID - Indonesia 42
UA - Ucraina 42
PL - Polonia 39
ZA - Sudafrica 36
NG - Nigeria 34
TR - Turchia 33
ES - Italia 32
TG - Togo 27
IQ - Iraq 25
BJ - Benin 24
AT - Austria 21
PK - Pakistan 20
UZ - Uzbekistan 19
EG - Egitto 18
CO - Colombia 17
RO - Romania 16
EC - Ecuador 15
VE - Venezuela 14
BE - Belgio 13
SA - Arabia Saudita 13
IR - Iran 12
AU - Australia 11
CH - Svizzera 11
PH - Filippine 11
CL - Cile 9
MA - Marocco 9
JO - Giordania 8
LT - Lituania 8
ET - Etiopia 7
PE - Perù 7
PT - Portogallo 7
QA - Qatar 7
AE - Emirati Arabi Uniti 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
AZ - Azerbaigian 5
HR - Croazia 5
KE - Kenya 5
KW - Kuwait 5
AL - Albania 4
BO - Bolivia 4
DK - Danimarca 4
GR - Grecia 4
IL - Israele 4
JM - Giamaica 4
LB - Libano 4
MY - Malesia 4
NP - Nepal 4
TN - Tunisia 4
UY - Uruguay 4
AM - Armenia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GE - Georgia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PS - Palestinian Territory 3
PY - Paraguay 3
RS - Serbia 3
SI - Slovenia 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GT - Guatemala 2
HN - Honduras 2
LK - Sri Lanka 2
ME - Montenegro 2
MK - Macedonia 2
SK - Slovacchia (Repubblica Slovacca) 2
SO - Somalia 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
BH - Bahrain 1
BN - Brunei Darussalam 1
Totale 16.797
Salva come PNG Salva come JPEG
Città #
Moscow 984
Singapore 980
Ashburn 852
Dallas 724
San Jose 623
Chandler 609
Southend 484
Hong Kong 364
Dublin 251
Verona 219
Beijing 208
Council Bluffs 174
The Dalles 165
New York 157
Los Angeles 153
Ho Chi Minh City 131
Jacksonville 131
Redmond 97
Princeton 84
Lawrence 83
Tokyo 79
Wilmington 78
Hanoi 75
Helsinki 75
Munich 70
Ann Arbor 62
Jinan 61
Houston 59
Shenyang 57
Buffalo 56
Redondo Beach 53
Woodbridge 52
Orem 51
Bologna 49
Santa Clara 49
São Paulo 48
London 47
Nanjing 46
Tianjin 45
Milan 41
Sindelfingen 39
San Francisco 38
Hyderabad 36
Rome 36
Hebei 34
Warsaw 33
Abuja 32
Columbus 32
Zhengzhou 32
Falkenstein 31
Montreal 31
Turku 31
Chicago 30
Hangzhou 28
Washington 28
Denver 27
Haikou 27
Lomé 27
Changsha 25
Seattle 25
Atlanta 24
Cotonou 24
Da Nang 22
Amsterdam 21
Johannesburg 21
Brooklyn 20
Guangzhou 20
Jakarta 20
Ningbo 20
Toronto 20
Boston 19
Phoenix 19
Tashkent 19
Chennai 18
Frankfurt am Main 18
Manchester 18
Poplar 18
Stockholm 17
Mexico City 16
Fairfield 15
Jiaxing 15
Nanchang 15
Redwood City 15
Seoul 15
Taiyuan 15
Taizhou 15
Biên Hòa 14
Haiphong 14
Mumbai 14
Rio de Janeiro 14
Dong Ket 13
Brussels 12
Shenzhen 12
Hải Dương 11
Norwalk 11
Paris 11
Vienna 11
Belo Horizonte 10
Nürnberg 10
Ankara 9
Totale 9.893
Salva come PNG Salva come JPEG
Nome #
Teriparatide and denosumab combination therapy and skeletal metabolism 348
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 267
Anti-CCP antibodies and bone 242
Type VI Osteogenesis imperfecta: effect of plasma transfusion on bone metabolism 224
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 222
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 214
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 209
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 207
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 203
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 201
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 198
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 191
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 191
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 190
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 187
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 187
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 187
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 182
The obesity paradox and osteoporosis 179
Cancer in adult patients with inflammatory arthritis is associated with high ascending aortic stiffness and left ventricular hypertrophy and diastolic dysfunction 172
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 170
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 170
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 167
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 165
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 164
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome 162
Association between environmental air pollution and rheumatoid arthritis flares 162
The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 161
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 161
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 159
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 158
Association between acute exposure to environmental air pollution and fragility hip fractures 157
Correction to: The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 157
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 155
Association between increased carotid intima-media thickness and higher serum C-terminal telopeptide of type 1 collagen levels in post-menopausal women with type 2 diabetes 155
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 153
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 152
Periostin: The bone and beyond 152
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 151
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 150
Drug-induced osteonecrosis of the jaw: the state of the art 150
Calcium and vitamin D supplementation: when and why 148
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 146
Effects of secukinumab on serum adipocytokines: preliminary data 143
Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome 142
Post-diagnosis serum 25-hydroxyvitamin D concentrations in women treated for breast cancer participating in a lifestyle trial in Italy 142
Rheumatoid arthritis, γδ T cells and bisphosphonates 142
Bone Geometry, Quality, and Bone Markers in Children with Type 1 Diabetes Mellitus 142
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 141
Acute Phase Reaction and Fracture Risk Reduction. Are Gamma‐Delta T Cells and hypovitaminosis D the Missing Link? 141
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 139
Duration of treatment for osteoporosis 139
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 139
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? 138
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 137
Changes in bone turnover markers and bone modulators during abatacept treatment 136
Osteoporosis in Rheumatic Diseases 134
The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis 133
Insight into the WNT system and its drug related response. 132
Correction to: The obesity paradox and osteoporosis 131
Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study 131
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 131
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 131
Bone Loss in Inflammatory Rheumatic Musculoskeletal Disease Patients Treated With Low-Dose Glucocorticoids and Prevention by Anti-Osteoporosis Medications 130
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 130
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis 128
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data 127
Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency 127
Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment 126
Bone health status evaluation in men by means of REMS technology 125
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 125
Eosinophilic Granulomatosis With Polyangiitis and Cardiac Involvement: A Case Report 124
Wnt pathway involvement and its response to treatment in the development of bone damage in different inflammatory and non-inflammatory rheumatic contidions 124
Vitamin D: not just bone, but also immunity 123
Radiological features of knee joint synovial chondromatosis 120
Ultrasonography of the nail unit reveals quantitative and qualitative alterations in patients with psoriasis and psoriatic arthritis 119
Vitamin D and Osteogenesis Imperfecta in Pediatrics 118
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 118
Clinical image: ultrasound findings and magnetic resonance imaging comparison in the muscular involvement in polyarteritis nodosa 114
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 114
Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs) 112
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 112
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritis 111
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 111
Romosozumab added to ongoing denosumab in postmenopausal osteoporosis, a prospective observational study 110
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 110
Pharmacological treatment in adult patients with CRPS-I: A systematic review and meta-analysis of randomised controlled trials 110
Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs) 109
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 108
Nail ultrasonography for psoriatic arthritis and psoriasis patients: a systematic literature review 107
Pharmacological management of osteoporosis in postmenopausal women: The current state of the art 107
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritis 105
Definition, Assessment, and Management of Vitamin D Inadequacy: Suggestions, Recommendations, and Warnings from the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS) 102
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 102
Ultrasonographic detection, definition and quantification of soft tissue oedema in psoriatic dactylitis 102
The Use of Oral Amino-Bisphosphonates and Coronavirus Disease 2019 (COVID-19) Outcomes 101
Long-Term Bone Mineral Density Changes in Kidney Transplant Recipients Treated with Denosumab: A Retrospective Study with Nonequivalent Control Group 96
Lack of Effect of Teriparatide on Joint Erosions in Rheumatoid Arthritis Is an Expected Result: Comment on the Article by Solomon et al 96
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 96
Machine learning to characterize bone biomarkers profile in rheumatoid arthritis 94
Totale 14.763
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.929
article - articoli 60.483
book - libri 0
conference - conferenze 670
curatela - curatele 0
other - altro 695
patent - brevetti 0
selected - selezionate 0
volume - volumi 81
Totale 123.858
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 0 0 0 0 0 0 0 0 0 51
2021/2022692 62 164 12 43 23 23 19 31 54 24 36 201
2022/20231.724 98 175 142 329 157 400 17 87 206 28 66 19
2023/20241.120 37 89 101 124 110 220 60 59 30 63 171 56
2024/20252.695 114 127 126 450 164 88 127 111 391 278 242 477
2025/20268.867 552 446 686 1.486 2.300 557 820 500 611 454 184 271
Totale 17.082